FR2446111A1 - Procede de preparation d'antigenes et vaccins obtenus selon ce procede - Google Patents

Procede de preparation d'antigenes et vaccins obtenus selon ce procede

Info

Publication number
FR2446111A1
FR2446111A1 FR7901301A FR7901301A FR2446111A1 FR 2446111 A1 FR2446111 A1 FR 2446111A1 FR 7901301 A FR7901301 A FR 7901301A FR 7901301 A FR7901301 A FR 7901301A FR 2446111 A1 FR2446111 A1 FR 2446111A1
Authority
FR
France
Prior art keywords
sodium
vaccines
complexes
prod
solubilisation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7901301A
Other languages
English (en)
French (fr)
Other versions
FR2446111B1 (US06534493-20030318-C00166.png
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR7901301A priority Critical patent/FR2446111A1/fr
Publication of FR2446111A1 publication Critical patent/FR2446111A1/fr
Application granted granted Critical
Publication of FR2446111B1 publication Critical patent/FR2446111B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
FR7901301A 1979-01-12 1979-01-12 Procede de preparation d'antigenes et vaccins obtenus selon ce procede Granted FR2446111A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7901301A FR2446111A1 (fr) 1979-01-12 1979-01-12 Procede de preparation d'antigenes et vaccins obtenus selon ce procede

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7901301A FR2446111A1 (fr) 1979-01-12 1979-01-12 Procede de preparation d'antigenes et vaccins obtenus selon ce procede

Publications (2)

Publication Number Publication Date
FR2446111A1 true FR2446111A1 (fr) 1980-08-08
FR2446111B1 FR2446111B1 (US06534493-20030318-C00166.png) 1982-07-02

Family

ID=9220943

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7901301A Granted FR2446111A1 (fr) 1979-01-12 1979-01-12 Procede de preparation d'antigenes et vaccins obtenus selon ce procede

Country Status (1)

Country Link
FR (1) FR2446111A1 (US06534493-20030318-C00166.png)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0182401A1 (en) * 1984-10-19 1986-05-28 De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur Vaccines comprising immunogenic protein or peptide complexes
WO1995015768A1 (de) * 1993-12-09 1995-06-15 Heinrich Exner Adjuvans für antigene, verfahren zur herstellung und verwendung

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE633375A (US06534493-20030318-C00166.png) *

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE633375A (US06534493-20030318-C00166.png) *

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CA1972 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0182401A1 (en) * 1984-10-19 1986-05-28 De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur Vaccines comprising immunogenic protein or peptide complexes
WO1995015768A1 (de) * 1993-12-09 1995-06-15 Heinrich Exner Adjuvans für antigene, verfahren zur herstellung und verwendung
DE4499552C1 (de) * 1993-12-09 1997-07-17 Heinrich Dr Exner Adjuvans für Antigene, Verfahren zur Herstellung und Verwendung
US5904925A (en) * 1993-12-09 1999-05-18 Exner; Heinrich Adjuvant for antigens, and process for making

Also Published As

Publication number Publication date
FR2446111B1 (US06534493-20030318-C00166.png) 1982-07-02

Similar Documents

Publication Publication Date Title
Aragozzini et al. Indole-3-lactic acid as a tryptophan metabolite produced by Bifidobacterium spp
EP0302781B1 (fr) Procédé d'obtention de polyosides capsulaires de staphylocoques, applications de ces polyosides et souches pour la mise en oeuvre du procédé
JP2001526902A5 (US06534493-20030318-C00166.png)
GB1439847A (en) Bacterial extracts
Kahan Isolation of a soluble transplantation antigen
Eddy et al. Part of the yeast surface apparently involved in flocculation
EP0731165A3 (en) Human T-cell line infected with HIV-2 which secretes functionally intact HIV-2 GP160
FR2446111A1 (fr) Procede de preparation d'antigenes et vaccins obtenus selon ce procede
Dodgson et al. Studies on sulphatases. 8. The arylsulphatase of a strain of Alcaligenes metalcaligenes isolated from inter-tidal mud
Barry et al. L-Fucosamine and 4-oxo-norleucine as constituents in mucopolysaccharides of certain enteric bacteria
FUJII et al. UCE1022, a new antitumor antibiotic with topoisomerase I mediated DNA cleavage activity, from Paecilomyces
GB1567106A (en) Microbial fractions
JPS568687A (en) Preparation of creatinase
Lee et al. Role of epoxide in neocarzinostatin chromophore stability and action.
Singh et al. Effect of xenogeneic immune RNA on normal human lymphocytes against human osteosarcoma cells in vitro
US4729955A (en) Method of producing reverse transcriptase
EP0226468A3 (en) Detection of human cancer cells with antibodies to human cancer nucleolar antigen p145
IT9021332A1 (it) Exopolimero ottenuto a partire da ceppi selezionati del genere bifidobaceterium, suo procedimento di preparazione e composizioni farmaceutiche che lo contengono
Kjellén On the capacity of pepsin-digested antibody to neutralize adenovirus infectivity
Kupchan et al. Zygadenus alkaloids. II. The occurrence of hypotensive germine esters in Zygadenus venenosus
West et al. Degradation of riboflavin by alimentary bacteria of the ruminant and man: production of 7, 8-dimethyl-10-carboxymethylisoalloxazine
Konishi et al. [53] Purification and assay of a proteolipid ionophore from yeast mitochondrial ATP synthetase
Homma et al. The surface structure of Pseudomonas aeruginosa
JPS6048929A (ja) 抗腫瘍剤
JPS62215551A (ja) 新規生理活性物質ｔｐｉおよびその製造法

Legal Events

Date Code Title Description
ST Notification of lapse